Deeply oversold/undervalued psychedelics playPsychedelics space has seen some multi-baggers in the span of the last 2 weeks, suggesting investors are once again starting to pour money into speculative shroom stocks.
CSE:LVT is deeply oversold (RSI @ 22.69), hitting all time lows. The company is deeply fundamentally undervalued:
- $1.87M market cap
- Raised $1.5M at 0.20 in February
- Generating revenue of over $2M per quarter
Some comparable psychedelic companies with less revenue are trading at more than 10x. Unless there's some kind of fundamental/unknown reason for recent selloff, other than weak general markets, this is a potential multi-bagger candidate from current levels, in my humble opinion. GLTA
